NO20034412L - Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse - Google Patents

Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse

Info

Publication number
NO20034412L
NO20034412L NO20034412A NO20034412A NO20034412L NO 20034412 L NO20034412 L NO 20034412L NO 20034412 A NO20034412 A NO 20034412A NO 20034412 A NO20034412 A NO 20034412A NO 20034412 L NO20034412 L NO 20034412L
Authority
NO
Norway
Prior art keywords
compounds
preparation
disclosed
mercaptoacetylamide derivatives
mercaptoacetylamide
Prior art date
Application number
NO20034412A
Other languages
English (en)
Other versions
NO20034412D0 (no
NO325655B1 (no
Inventor
Gary A Flynn
Shujaath Mehdi
Jack Roger Koehl
Barbara Ann Anderson
Manfred Gerken
Bernd Jablonka
Heinz-Werner Kleemann
Wolfgang Linz
Werner Seiz
Bernhard Seuring
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20034412D0 publication Critical patent/NO20034412D0/no
Publication of NO20034412L publication Critical patent/NO20034412L/no
Publication of NO325655B1 publication Critical patent/NO325655B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
NO20034412A 2001-04-12 2003-10-02 Merkaptoacetylamidderivater, fremgangsmate for deres fremstilling og deres anvendelse samt farmasoytisk sammensetning og fremgangsmate for fremstilling derav NO325655B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Publications (3)

Publication Number Publication Date
NO20034412D0 NO20034412D0 (no) 2003-10-02
NO20034412L true NO20034412L (no) 2003-10-02
NO325655B1 NO325655B1 (no) 2008-06-30

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034412A NO325655B1 (no) 2001-04-12 2003-10-02 Merkaptoacetylamidderivater, fremgangsmate for deres fremstilling og deres anvendelse samt farmasoytisk sammensetning og fremgangsmate for fremstilling derav

Country Status (26)

Country Link
EP (1) EP1381605B1 (no)
JP (1) JP4392167B2 (no)
CN (1) CN1245404C (no)
AT (1) ATE286898T1 (no)
AU (1) AU2002304804B2 (no)
BG (1) BG66387B1 (no)
BR (1) BR0208889A (no)
CA (1) CA2443488C (no)
CZ (1) CZ299708B6 (no)
DE (1) DE60202602T2 (no)
EE (1) EE05272B1 (no)
ES (1) ES2232752T3 (no)
HR (1) HRP20030823B1 (no)
HU (1) HU229612B1 (no)
IL (1) IL158289A0 (no)
MA (1) MA26098A1 (no)
MX (1) MXPA03008613A (no)
NO (1) NO325655B1 (no)
NZ (1) NZ528825A (no)
OA (1) OA12502A (no)
PL (1) PL209338B1 (no)
PT (1) PT1381605E (no)
RU (1) RU2286346C2 (no)
SI (1) SI1381605T1 (no)
SK (1) SK287616B6 (no)
WO (1) WO2002083671A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2078758C (en) * 1991-09-27 2003-12-09 Alan M. Warshawsky 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
RU2127261C1 (ru) * 1993-06-11 1999-03-10 Эйсаи Ко., ЛТД Производные аминокислоты
JP3563738B2 (ja) * 1993-06-11 2004-09-08 エーザイ株式会社 アミノ酸誘導体

Also Published As

Publication number Publication date
SI1381605T1 (en) 2005-06-30
HK1061690A1 (en) 2004-09-30
PL363034A1 (en) 2004-11-15
SK12552003A3 (sk) 2004-03-02
NO20034412D0 (no) 2003-10-02
PL209338B1 (pl) 2011-08-31
BG108203A (bg) 2004-12-30
NO325655B1 (no) 2008-06-30
DE60202602D1 (de) 2005-02-17
MXPA03008613A (es) 2003-12-08
NZ528825A (en) 2005-04-29
OA12502A (fr) 2006-05-29
CA2443488C (en) 2011-05-31
HUP0303482A2 (hu) 2004-01-28
JP4392167B2 (ja) 2009-12-24
CA2443488A1 (en) 2002-10-24
HRP20030823A2 (en) 2005-08-31
HUP0303482A3 (en) 2012-12-28
PT1381605E (pt) 2005-03-31
BG66387B1 (bg) 2013-11-29
SK287616B6 (sk) 2011-04-05
ES2232752T3 (es) 2005-06-01
ATE286898T1 (de) 2005-01-15
EE05272B1 (et) 2010-02-15
RU2286346C2 (ru) 2006-10-27
WO2002083671A1 (en) 2002-10-24
MA26098A1 (fr) 2004-04-01
CN1501926A (zh) 2004-06-02
DE60202602T2 (de) 2006-03-23
IL158289A0 (en) 2004-05-12
HRP20030823B1 (en) 2011-10-31
CZ20032722A3 (cs) 2004-01-14
JP2004525966A (ja) 2004-08-26
HU229612B1 (en) 2014-03-28
BR0208889A (pt) 2004-06-29
AU2002304804B2 (en) 2007-05-10
EP1381605B1 (en) 2005-01-12
CN1245404C (zh) 2006-03-15
RU2003132875A (ru) 2005-03-20
EP1381605A1 (en) 2004-01-21
EE200300500A (et) 2003-12-15
CZ299708B6 (cs) 2008-10-29

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
WO2004033632A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
MXPA03009380A (es) Derivados de pirazol.
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
WO2004064730A3 (en) Compounds, compositions and methods
WO2003082857A3 (en) Lansoprazole polymorphs and processes for preparation thereof
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
AU2002316459A1 (en) Methods of treating cytokine mediated diseases
WO2002065834A3 (en) Novel formulations of carvedilol
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
WO2004012663A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
WO2003059258A3 (en) Compositions and methods for treating heart failure
WO2004108086A3 (en) HYDANTOIN DERIVATIVES AS INHIBITORS OF TUMOR NECROSIS FACTOR-α CONVERTING ENZYME (TACE)
WO2004032908A3 (en) Method of inhibiting angiogenesis
WO2003059265A3 (en) Compositions and methods for treating heart failure
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
NO20034412D0 (no) Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse
MXPA04003910A (es) Uso de irbesartan para la preparacion de medicamentos que son utiles para la prevencion o tratamiento de hipertension pulmonar.
WO2003028645A3 (en) Novel compositions of carvedilol
DK1387841T3 (da) Hidtil ukendt azol- eller triazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som fungicider
WO2003097593A3 (en) Protease inhibitors
AU2002326391A1 (en) Carvedilol polymorph
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees